Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

13 questions · 14 findings · 2 reviews

No studies found 1 · 7.1%GRADE not reported 0 · 0%Very low 5 · 35.7%Low 3 · 21.4%Moderate 4 · 28.6%High 1 · 7.1%

Summary of findings table ‐ Support plus vs usual care

Stopping breastfeeding (any) at 4‐6 weeks · healthy breastfeeding women with healthy term babies

Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 4‐6 weeks compared with usual care (moderate certainty).

1 finding from 1 review

Summary of findings table ‐ Support plus vs usual care

Stopping exclusive breastfeeding at 4‐6 weeks · healthy breastfeeding women with healthy term babies

It is very uncertain whether summary of findings table ‐ Support plus changes stopping exclusive breastfeeding at 4‐6 weeks compared with usual care (very low certainty).

1 finding from 1 review

Summary of findings table ‐ Support plus vs usual care

Stopping exclusive breastfeeding at 2 months · healthy breastfeeding women with healthy term babies

It is very uncertain whether summary of findings table ‐ Support plus changes stopping exclusive breastfeeding at 2 months compared with usual care (very low certainty).

2 findings from 1 review

Summary of findings table (subcomparison 1): chemotherapy or targeted therapy plus best supportive care (BSC) vs BSC

Overall survival · palliative participants with esophageal and GE‐junction carcinoma

Summary of findings table (subcomparison 1): chemotherapy or… leads to lower overall survival compared with BSC (high certainty).

1 finding from 1 review

Summary of findings table (subcomparison 1): chemotherapy or targeted therapy plus best supportive care (BSC) vs BSC

Progression‐free survival · palliative participants with esophageal and GE‐junction carcinoma

It is very uncertain whether summary of findings table (subcomparison 1): chemotherapy or… changes progression‐free survival compared with BSC (very low certainty).

1 finding from 1 review

Summary of findings table (subcomparison 1): chemotherapy or targeted therapy plus best supportive care (BSC) vs BSC

Toxicity · palliative participants with esophageal and GE‐junction carcinoma

It is very uncertain whether summary of findings table (subcomparison 1): chemotherapy or… changes toxicity compared with BSC (very low certainty).

1 finding from 1 review